Trial Profile
A phase I/II study of radiation therapy, paclitaxel poliglumex and cetuximab in advanced head and neck cancer.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 11 Nov 2021
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Paclitaxel poliglumex (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- 29 Oct 2021 Status changed from recruiting to completed.
- 22 Mar 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 22 Mar 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.